Original Research

Published on 25 Oct 2024

Integration of transcriptomics and machine learning for insights into breast cancer: exploring lipid metabolism and immune interactions

in Cancer Immunity and Immunotherapy

Xiaohan Chen
Jinfeng Yi
Lili Xie
Tong Liu
Baogang Liu
Meisi Yan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1470167

487 views

Original Research

Published on 24 Oct 2024

Effect of peripheral blood lymphocyte count on the efficacy of immunotherapy combined with TKI in the treatment of advanced liver cancer

in Cancer Immunity and Immunotherapy

Qian Zhao
Lei Wang
Huilan Fu
Yuqin Zhang
Qiankun Xie

Frontiers in Immunology

doi 10.3389/fimmu.2024.1467429

448 views

Original Research

Published on 24 Oct 2024

Identification of beneficial populations for targeted-immunotherapy combinations: tailoring later-line care for patients with pMMR/MSS metastatic colorectal cancer

in Cancer Immunity and Immunotherapy

Dan Li
Hui Jin
Yan Liu
Jiayin Liu
Xue Zhang
Long Wang
Zhisong Fan
Li Feng
Jing Zuo
Jing Han

Frontiers in Immunology

doi 10.3389/fimmu.2024.1462346

312 views

Review

Published on 24 Oct 2024

Genetically modified and unmodified cellular approaches to enhance graft versus leukemia effect, without increasing graft versus host disease: the use of allogeneic cytokine-induced killer cells

in Cancer Immunity and Immunotherapy

Benedetta Rambaldi
Giuliana Rizzuto
Alessandro Rambaldi
Martino Introna

Frontiers in Immunology

doi 10.3389/fimmu.2024.1459175

516 views

Original Research

Published on 24 Oct 2024

Analysis of the treatment efficacy and prognostic factors of PD-1/PD-L1 inhibitors for advanced gastric or gastroesophageal junction cancer: a multicenter, retrospective clinical study

in Cancer Immunity and Immunotherapy

Yuanyuan Yang
Zhe Wang
Dao Xin
Lulu Guan
Bingtong Yue
Qifan Zhang
Feng Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1468342

651 views

Original Research

Published on 24 Oct 2024

Targeting TGFβ with chimeric switch receptor and secreted trap to improve T cells anti-tumor activity

in Cancer Immunity and Immunotherapy

Tatyana Matikhina
Cyrille J. Cohen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1460266

485 views

Original Research

Published on 24 Oct 2024

Tumor-related IGF2BP1-derived molecular subtypes to predict prognosis and immune microenvironment in head and neck squamous cell carcinoma

in Cancer Immunity and Immunotherapy

Qin Ding
Mingzhu Liu
Yuhui Pan
Ziyi Wu
Jing Wang
Yi Li
Xiaoyong Liu
Jinghua Lai
Dan Hu
Sufang Qiu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1469435

535 views

Original Research

Published on 24 Oct 2024

Lipidome analyses reveal radiation induced remodeling of glycerophospholipid unsaturation in lung tumor

in Cancer Immunity and Immunotherapy

Jingquan He
Qingqing Yuan
Song Gao
Yue Wang
Haigen Lai
Kaiting Wang
Xiaoman Zhou
Zicheng Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1470269

281 views

Case Report

Published on 24 Oct 2024

Sarcomatoid carcinoma transformation in oral undifferentiated carcinoma following sequential immune combined targeted therapy: a case report

in Cancer Immunity and Immunotherapy

Jieying Li
Xiaohong Zhan
Wei Shang
Kai Song

Frontiers in Immunology

doi 10.3389/fimmu.2024.1484915

242 views

Original Research

Published on 23 Oct 2024

Comparing PD-L1 with PD-1 antibodies combined with lenvatinib and hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Shaohua Li
Jie Mei
Rongce Zhao
Jing Zhou
Qiaoxuan Wang
Lianghe Lu
Jibin Li
Lie Zheng
Wei Wei
Rongping Guo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1491857

1,109 views

Original Research

Published on 23 Oct 2024

LC-MS/MS analysis reveals plasma protein signatures associated with lymph node metastasis in colorectal cancer

in Cancer Immunity and Immunotherapy

Chunsong Pang
Fang Xu
Yingwei Lin
WeiPing Han
Nianzhu Zhang
Lifen Zhao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1465374

1,248 views

Review

Published on 23 Oct 2024

Investigating tumor immunogenicity in breast cancer: deciphering the tumor immune response to enhance therapeutic approaches

in Cancer Immunity and Immunotherapy

Oumayma Naji
Amina Ghouzlani
Soumaya Rafii
Rizwan ullah Sadiqi
Abdou-samad Kone
Zakia Harmak
Khalil Choukri
Sarah Kandoussi
Mehdi Karkouri
Abdallah Badou

Frontiers in Immunology

doi 10.3389/fimmu.2024.1399754

1,338 views

Mini Review

Published on 23 Oct 2024

Molecular and modular intricacies of precision oncology

in Cancer Immunity and Immunotherapy

Ravneet Chhabra

Frontiers in Immunology

doi 10.3389/fimmu.2024.1476494

717 views

Systematic Review

Published on 23 Oct 2024

Prognostic value of neutrophil-to-lymphocyte ratio in patients with non–muscle-invasive bladder cancer with intravesical Bacillus Calmette–Guérin immunotherapy: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Jiaguo Huang
Li Lin
Dikai Mao
Runmiao Hua
Feifei Guan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1464635

920 views

Case Report

Published on 23 Oct 2024

Lung enteric-type adenocarcinoma with gastric metastasis: a rare case report and literature review

in Cancer Immunity and Immunotherapy

Xiaoning Li
Kewei Ma
Xiaobo Ma
Xiangye Zhao
Mengge Fan
Yinghui Xu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1486214

986 views

Original Research

Published on 23 Oct 2024

Comprehensive single-cell and bulk transcriptomic analyses to develop an NK cell-derived gene signature for prognostic assessment and precision medicine in breast cancer

in Cancer Immunity and Immunotherapy

Qianshan Hou
Chunzhen Li
Yuhui Chong
Haofeng Yin
Yuchen Guo
Lanjie Yang
Tianliang Li
Shulei Yin

Frontiers in Immunology

doi 10.3389/fimmu.2024.1460607

1,690 views

Navigation group

Articles

Integration of transcriptomics and machine learning for insights into breast cancer: exploring lipid metabolism and immune interactions

Effect of peripheral blood lymphocyte count on the efficacy of immunotherapy combined with TKI in the treatment of advanced liver cancer

Identification of beneficial populations for targeted-immunotherapy combinations: tailoring later-line care for patients with pMMR/MSS metastatic colorectal cancer

Genetically modified and unmodified cellular approaches to enhance graft versus leukemia effect, without increasing graft versus host disease: the use of allogeneic cytokine-induced killer cells

Analysis of the treatment efficacy and prognostic factors of PD-1/PD-L1 inhibitors for advanced gastric or gastroesophageal junction cancer: a multicenter, retrospective clinical study

Targeting TGFβ with chimeric switch receptor and secreted trap to improve T cells anti-tumor activity

Tumor-related IGF2BP1-derived molecular subtypes to predict prognosis and immune microenvironment in head and neck squamous cell carcinoma

Lipidome analyses reveal radiation induced remodeling of glycerophospholipid unsaturation in lung tumor

Sarcomatoid carcinoma transformation in oral undifferentiated carcinoma following sequential immune combined targeted therapy: a case report

Comparing PD-L1 with PD-1 antibodies combined with lenvatinib and hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma

LC-MS/MS analysis reveals plasma protein signatures associated with lymph node metastasis in colorectal cancer

Investigating tumor immunogenicity in breast cancer: deciphering the tumor immune response to enhance therapeutic approaches

Molecular and modular intricacies of precision oncology

Prognostic value of neutrophil-to-lymphocyte ratio in patients with non–muscle-invasive bladder cancer with intravesical Bacillus Calmette–Guérin immunotherapy: a systematic review and meta-analysis

Lung enteric-type adenocarcinoma with gastric metastasis: a rare case report and literature review

Comprehensive single-cell and bulk transcriptomic analyses to develop an NK cell-derived gene signature for prognostic assessment and precision medicine in breast cancer